Brief: Angion Biomedia Corp. Announces 1-For-10 Reverse Stock Split
June 1 (Reuters) - Angion Biomedica Corp ANGN.O :
* ANGION BIOMEDIA CORP. ANNOUNCES 1-FOR-10 REVERSE STOCK
SPLIT
* ANGION BIOMEDICA CORP - WILL EFFECT A REVERSE STOCK SPLIT
OF ITS
OUTSTANDING SHARES OF COMMON STOCK AT A RATIO OF 1-FOR-10
* ANGION BIOMEDICA CORP - COMMON STOCK WILL BEGIN TRADING ON
A
SPLIT-ADJUSTED BASIS WHEN MARKET OPENS ON JUNE 2 UNDER NEW
TRADING SYMBOL "ELTX."
Source text for Eikon: ID:nGNX7fyTyw
Further company coverage: ANGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Elicio Therapeutics
See all newsFactbox: Moderna-Merck melanoma vaccine leads race for first therapeutic cancer vaccine
Elicio Therapeutics Q2 net loss narrows as R&D expenses fall
Elicio Therapeutics Inc expected to post a loss of 54 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Datadog, Terawulf, Paychex
Elicio shares slide after pancreatic cancer vaccine falls short in mid-stage study (updated)